WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (NASDAQ:NURO, NUROW) announced today that Shai N. Gozani, M.D., Ph.D., President and Chief Executive Officer of NeuroMetrix , is scheduled to speak at the 2016 Sidoti Emerging Growth Convention at the Marriott Marquis in New York City on
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) today announced that Dr. Xuan Kong, SVP, Research and Intellectual Property, will present the Company's DPNCheck ® technology at the 5 th Annual Diabetic Peripheral Neuropathy Fellowship for Chinese Physicians at the
NeuroMetrix to Present at 5th Annual OneMedForum San Francisco 2012 WALTHAM, Mass.--(BUSINESS WIRE)--Jan. 3, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today announced that Shai N.
NeuroMetrix to Present at 6th Annual OneMedForum San Francisco 2013 WALTHAM, Mass. --(BUSINESS WIRE)--Jan. 2, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today announced
NeuroMetrix to Present at 7th Annual OneMedForum: Investing in Healthcare 2014 WALTHAM, Mass. --(BUSINESS WIRE)--Dec. 4, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), www.SENSUS Rx .com , a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. announced today that Shai N. Gozani M.D ., Ph.D., President and Chief Executive Officer, will be presenting at the Biotech Showcase 2015 Conference being held in San Francisco, CA. Dr. Gozani intends to provide an overall business update and a
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. announced today that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, will be presenting at the Biotech Showcase 2016 Conference being held in San Francisco, CA. Dr. Gozani intends to provide an overall business update and a
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO, NUROW) announced today that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, will be presenting at the Biotech Showcase 2017 Conference being held at the Hilton San Francisco Union Square in San Francisco,
NeuroMetrix to Present at Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference WALTHAM, Mass. --(BUSINESS WIRE)--Nov. 29, 2011-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of
NeuroMetrix to Present at Canaccord Genuity Growth Conference WALTHAM, Mass., Aug 02, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), a science-based health care company improving patient care through neurotechnology, today announced that Shai N.
